| Metalloproteinases in biology and pathology of the nervous system VW Yong, C Power, P Forsyth, DR Edwards Nature Reviews Neuroscience 2 (7), 502-511, 2001 | 1250 | 2001 |
| Matrix metalloproteinases and diseases of the CNS VW Yong, PA Forsyth, R Bell, CA Krekoski, DR Edwards Trends in neurosciences 21 (2), 75-80, 1998 | 809 | 1998 |
| Metalloproteinases: mediators of pathology and regeneration in the CNS VW Yong Nature Reviews Neuroscience 6 (12), 931-944, 2005 | 699 | 2005 |
| The promise of minocycline in neurology VW Yong, J Wells, F Giuliani, S Casha, C Power, LM Metz The Lancet Neurology 3 (12), 744-751, 2004 | 618 | 2004 |
| Pro‐regenerative properties of cytokine‐activated astrocytes CM Liberto, PJ Albrecht, LM Herx, VW Yong, SW Levison Journal of neurochemistry 89 (5), 1092-1100, 2004 | 588 | 2004 |
| Pathophysiology of the brain extracellular matrix: a new target for remyelination LW Lau, R Cua, MB Keough, S Haylock-Jacobs, VW Yong Nature Reviews Neuroscience 14 (10), 722-729, 2013 | 584 | 2013 |
| Inefficient clearance of myelin debris by microglia impairs remyelinating processes A Lampron, A Larochelle, N Laflamme, P Préfontaine, MM Plante, ... Journal of Experimental Medicine 212 (4), 481-495, 2015 | 566 | 2015 |
| Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. M Nguyen, DG Millar, VW Yong, SJ Korsmeyer, GC Shore Journal of Biological Chemistry 268 (34), 25265-25268, 1993 | 553 | 1993 |
| Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis V Brundula, NB Rewcastle, LM Metz, CC Bernard, VW Yong Brain 125 (6), 1297-1308, 2002 | 546 | 2002 |
| Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice JEA Wells, RJ Hurlbert, MG Fehlings, VW Yong Brain 126 (7), 1628-1637, 2003 | 522 | 2003 |
| Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases C Power, S Henry, MR Del Bigio, PH Larsen, D Corbett, Y Imai, VW Yong, ... Annals of neurology 53 (6), 731-742, 2003 | 504 | 2003 |
| Interferon beta in the treatment of multiple sclerosis: mechanisms of action V Wee Yong, S Chabot, O Stuve, G Williams Neurology 51 (3), 682-689, 1998 | 499 | 1998 |
| Endocrine disrupting chemicals and immune responses: A focus on bisphenol-A and its potential mechanisms JA Rogers, L Metz, VW Yong Molecular immunology 53 (4), 421-430, 2013 | 477 | 2013 |
| Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients TL Perry, VW Yong Neuroscience letters 67 (3), 269-274, 1986 | 465 | 1986 |
| CXCR4 is a major chemokine receptor on glioma cells and mediates their survival Y Zhou, PH Larsen, C Hao, VW Yong Journal of Biological Chemistry 277 (51), 49481-49487, 2002 | 464 | 2002 |
| Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis A Bar‐Or, RK Nuttall, M Duddy, A Alter, HJ Kim, I Ifergan, CJ Pennington, ... Brain 126 (12), 2738-2749, 2003 | 459 | 2003 |
| Interferon β‐1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase‐9 O Stüve, NP Dooley, JH Uhm, JP Antel, GS Francis, VW Yong, G Williams Annals of Neurology: Official Journal of the American Neurological …, 1996 | 454 | 1996 |
| Human endogenous retrovirus glycoprotein–mediated induction of redox reactants causes oligodendrocyte death and demyelination JM Antony, G Van Marle, W Opii, DA Butterfield, F Mallet, VW Yong, ... Nature neuroscience 7 (10), 1088-1095, 2004 | 450 | 2004 |
| Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines V Balasingam, T Tejada-Berges, E Wright, R Bouckova, VW Yong Journal of Neuroscience 14 (2), 846-856, 1994 | 444 | 1994 |
| Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury S Casha, D Zygun, MD McGowan, I Bains, VW Yong, R John Hurlbert Brain 135 (4), 1224-1236, 2012 | 421 | 2012 |
